No insider purchase over the last 90 days. The latest was filed 19 Nov 2024.
This page follows insider dealings at Assertio Holdings, Inc. as filed with SEC (Form 4), a company from the Health Care sector based in Newark, United States. The group dates from 1995. The last twelve months, up to 18 October 2026, brought 25 filings signed by 9 insiders.
Only sales appear on the open market, 1 sale in all totalling €5,896, filed by 1 insider. Stark David Matthew filed the largest sale, €5,896, on 12 November 2025.
Across the 5,816 companies tracked on its exchange, the median is 19 filings; at 25 filings, this issuer sits above that mark. Over the whole record (from 2021), the tally stands at 7 purchases and 13 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 118.7 m USD and net income at -30.4 m USD.
Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Assertio Holdings, Inc. Buy (bullish), based on 3 analysts. Average price target: US$24.43.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 130 declarations
Assertio Holdings, Inc. is a company focused on the development and commercialization of pharmaceutical products. It is listed on the NASDAQ under the ticker ASRT.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Newark, United States · Founded: 1995 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 118.7 m USD | -30.4 m USD | -4.74 USD | 10-K |
| Dec 2024 | 125.0 m USD | -21.6 m USD | -3.40 USD | 10-K |
| Dec 2023 | 152.1 m USD | -331.9 m USD | -4.67 USD | 10-K |
| Dec 2022 | 156.2 m USD | 109.6 m USD | 2.03 USD | 10-K |
| Dec 2021 | 111.0 m USD | -1.3 m USD | -0.03 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.